Study Schedule and Safety Outcome Measures
TB
Participants were screened and enrolled within 5 days of commencing TB treatment. They were assessed at 5 subsequent study visits (days 3, 7, 14, 28, and 56) at which point they were referred to government TB clinics for continuation therapy (